scholarly journals Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain

2018 ◽  
Vol 35 (11) ◽  
pp. 1920-1934 ◽  
Author(s):  
Miguel Salavert ◽  
Javier Cobo ◽  
Álvaro Pascual ◽  
Belén Aragón ◽  
Stefano Maratia ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Clostridium Difficile ◽  
Clostridium Difficile Infection ◽  
Standard Of Care ◽  
Cost Effectiveness Analysis ◽  
High Risk Patients ◽  
Recurrent Clostridium Difficile Infection ◽  
Effectiveness Analysis ◽  
Risk Patients

scholarly journals Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection

PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0149521 ◽  
Author(s):  
Lauren Lapointe-Shaw ◽  
Kim L. Tran ◽  
Peter C. Coyte ◽  
Rebecca L. Hancock-Howard ◽  
Jeff Powis ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Clostridium Difficile ◽  
Clostridium Difficile Infection ◽  
Cost Effectiveness Analysis ◽  
Recurrent Clostridium Difficile Infection ◽  
Effectiveness Analysis

Cost-Effectiveness Analysis of Protected Carotid Artery Stent Placement Versus Endarterectomy in High-Risk Patients

2010 ◽  
Vol 17 (2) ◽  
pp. 224-229 ◽  
Author(s):  
Alberto Maud ◽  
Gabriela Vázquez ◽  
John A. Nyman ◽  
Kamakshi Lakshminarayan ◽  
David C. Anderson ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Carotid Artery ◽  
Stent Placement ◽  
Cost Effectiveness Analysis ◽  
High Risk Patients ◽  
Carotid Artery Stent ◽  
Effectiveness Analysis ◽  
Risk Patients
Sign in / Sign up

Export Citation Format

Share Document